Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MD-1 expression regulates direct and indirect allorecognition.

S Hadidi1, R M Gorczynski

  • 1Transplant Research Division, The Toronto Hospital, Toronto, Ontario, Canada. sima.hadidi@tbrc.mgh.harvard.edu

Tissue Antigens
|January 7, 2004
PubMed
Summary

Blocking MD-1 molecule expression in graft recipients or donors can reduce immune rejection of skin grafts. Targeting both donor and recipient MD-1 optimally inhibits cytotoxic T lymphocyte responses and promotes graft survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined IMIG and Immune Ig Attenuate Allergic Responses in Beagle Dogs.

Journal of immunology research·2020
Same author

Combined IMIG and immune Ig attenuates inflammatory colitis in mice.

International immunopharmacology·2020
Same author

IL-17 Signaling in the Tumor Microenvironment.

Advances in experimental medicine and biology·2020
Same author

Mechanism(s) of prolonged attenuation of allergic responses after modulation of idiotypic regulatory network.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2019
Same author

Corrigendum to "An altered REDOX environment, assisted by over-expression of fetal hemoglobins, protects from inflammatory colitis and reduces inflammatory cytokine expression" [Int. Immunopharmacol. 50 (2017) 69-76].

International immunopharmacology·2018
Same author

Corrigendum to "Regulation of fetal hemoglobin expression during hematopoietic stem cell development and its importance in bone metabolism and osteoporosis" [Int. Immunopharmacol. 57 (2018) 112-120].

International immunopharmacology·2018

Area of Science:

  • Immunology
  • Transplantation Biology
  • Molecular Medicine

Background:

  • MD-1 molecule expression is known to influence allogeneic and xenogeneic skin graft survival.
  • Previous studies showed decreased graft rejection with functional blockade of MD-1, but it was unclear if donor or recipient cell blockade was critical.

Purpose of the Study:

  • To investigate the impact of MD-1 blockade on allorecognition in skin transplantation.
  • To determine whether targeting donor cells, recipient cells, or both is most effective in modulating immune responses.

Main Methods:

  • Utilized antisense oligodeoxynucleotides (ODNs) to block MD-1 expression in skin graft donors and/or recipients.
  • Studied fully MHC-mismatched and minor antigen-mismatched allogeneic skin grafts.
  • Assessed graft-specific cytotoxic T lymphocyte (CTL) responses, cell proliferation, and cytokine production (IL-2, IFN-gamma, IL-4, IL-10).

Related Experiment Videos

Main Results:

  • CTL responses to minor-incompatible grafts were reduced only when recipients were treated with ODNs.
  • Treatment of both donor and recipient of MHC-incompatible grafts maximally inhibited CTL production.
  • Suppression of CTLs correlated with reduced proliferation and a shift towards IL-4/IL-10 production over IL-2/IFN-gamma.

Conclusions:

  • MD-1 expression regulates both direct and indirect pathways of allorecognition.
  • Targeting MD-1 expression offers a potential strategy for modulating clinical graft rejection.
  • Understanding MD-1's role is crucial for improving transplant outcomes.